Uploaded by lmjohnson125

Cancer Overview(1).pptx WEEK 3

advertisement
IMMUNIT Y I:
SOLID TUMORS
EPIDEMIOLOGY
• Age
• Race
• Genetics; breast cancer
• Lifestyle; smokinglung cancer, colon
cancerlots of red meat
• Environment
• Other conditions
• Social determinants- access to health
care could cause cancer to progress and
become untreatable
• Proto-oncogenes promote cell growth, but…
• Mutation (external vs. internal) changes them to…
Carcinogenesis • Oncogenes which turn normal cells into cancer cells.
Immunology
• Immunologic surveillance monitors the body with…
• T cells, NK, B cells, macrophages unless…
• Immunologic escape through immune suppression,
weak/blocked antigens, or tolerance to antigens.
SCIENTIFIC
BASIS
Carcinogenesis
And
Immunology
Carcinogenesis
• Angiogenesis creates means for tumors to grow, and
• Metastasis allows them to spread further in the body.
COMMON METASTATIC LOCATIONS
Cancer Type
Breast
Colorectal
Lung
Pancreas
Prostate
Main Sites of Metastasis
Bone, brain, liver, lung
Liver, lung, peritoneum
Adrenal gland, bone, brain, liver, other lung
Liver, lung, peritoneum
Adrenal gland, bone, liver, lung
DIAGNOSTIC MEASURES
• Radiographic studies
– CT, MRIs, PET scans
• Blood work
– CBC: WBC count, platelets, hgb, hct,
tumor markers (PSA, CA125, HCG)..
Do not guarantee a diagnosis TM
• Endoscopy: thru mouth
• Biopsy
• Definitive diagnosis made through tissue
examination
CLASSIFICATION
• Origin tissue
• Anatomic site
• Nature of tumor
• An adenocarcinoma of the lung tells us
– Origin: adeno- indicates glandular epithelium
– Anatomic site: lung
– Nature: -carcinoma indicates malignancy
STAGING
• Clinical staging used for many tumor types
–I
local growth
small, localized
– II
local spread
some adjacent lymph node involvement
– III
local/regional spread
spread to nearby structures
– IV
metastasis
distant spread
TREATMENT
MODALITIES
• Surgery
• Radiation therapy
• Chemotherapy
• Biotherapy
• Immunotherapy
• Targeted therapy
SURGERY
• Prevention
– Ex. Mastectomy, hysterectomy, ovaries
removed
• Cure: tumor removal (stage 1 or 2, maybe 3)
• Control/cure
– Neoadjuvant: doing the surgery before
any tx is done
– Adjuvant: after primary tx such as
chemo, this is done when tumor is too big
to remove initially
• Palliation: doing it for comfort (stage 4)
RADIATION
• Cure/control or palliation
• Teletherapy: sends external beams directly to target cancer
– Brain, colon, lung
• Brachytherapy: small seeds placed in area of cancer with hope to cure
– Uterine, ovarian, head/neck, prostate cancer, eye
– 2x a day for 2-5 days or once a week for 2-5 weeks
• Nursing safety: Remember ALARA and T-D-S!
• Common side effects:
– Skin desquamation: burning of skin, skin break down (most common)
– Others depend on site: diarrhea, mucositis, anorexia, pneumonitis, pericarditis
CHEMOTHERAPY
• Cure/control or palliation
• Regimens created based on effect on cells, toxicity profiles
– Cell-cycle phase specific vs. cell-cycle phase non-specific
• Drugs can’t distinguish between normal and cancer cells. Side effects result from
destruction of normal cells and depend on class of drug.
– Most common side effects: myelosuppression, N/V, neuropathy, fatigue
• Given IV or regionally: oral, intraperitoneal, intrathecal, intravesicular, intrapleural
– direct to tumor site = less systemic toxicity
• Nursing safety
– Special PPE needed. Chemo typically administered by specially trained nurses.
• What is the difference between cell
cycle specific and nonspecific?
• What impact do growth rate and cell
cycle have on an agent’s effectiveness?
• Why are CNS tumors difficult to treat?
• When is regional therapy most useful?
• Why are CVADs recommended for
chemotherapy administration?
C H E M OT H E R A P Y
CRITICAL
THINKING
QUESTIONS
BIOTHERAPY, IMMUNOTHERAPY, AND
TARGETED THERAPY: NOT CHEMO
• Work differently than chemotherapy
– Attack cancer cells via receptors/antigens, inhibit molecules/enzymes, boost
immune system
– i.e. monoclonal antibodies: bevacizumab for lung cancer, trastuzumab for
breast cancer
• Side effects
– Infusion reactions (fever, chills, rash, dyspnea, etc)
– Flu-like symptoms
SIDE EFFECT CONSIDERATIONS
• Acute vs. delayed vs. chronic
– Acute
– Delayed
– Chronic
• Tolerable vs. toxic
– Tolerable – managed with interventions
– Toxic – dose-limiting (if they are vomiting uncontrollably)
• Secondary malignancies
– Increased risk with alkylating agents, high dose radiation
SYMPTOM
MANAGEMENT
NURSING ASSESSMENT FINDINGS
• Increased intracranial pressure
• Constipation
• Peripheral neuropathy
• Hemorrhagic cystitis: blood in urine
• Cognitive difficulties
• Myelosuppression, including nadir
• Mucositis
• Hyperuricemia
• Nausea/vomiting
• Alopecia- hair loss
• Anorexia
• Radiation “burns”
• Diarrhea
• Fatigue
ADDITIONAL PSYCHOSOCIAL
FINDINGS
•
•
•
•
•
•
•
•
•
Pervasive anxiety and fear, loss of control
Decisional conflicts: information overload!
Relationship stress: altered family roles and isolation
Financial burden
Altered body image
Denial
Grief
Depression
Impaired intimacy and sexual dysfunction
NURSING DIAGNOSES
• Activity intolerance
• Impaired skin integrity
• Anxiety
• Insomnia
• Chronic pain
• Nausea
• Constipation
• Risk for bleeding
• Diarrhea
• Risk for imbalanced fluid volume
• Disturbed body image
• Risk for infection
• Imbalanced nutrition
• Self-care deficit
• Impaired oral mucous membrane
• Impaired physical mobility
SAMPLE NURSING INTERVENTIONS
• Neuropathy:
– Consider gabapentin, encourage diligent foot care
• Cognitive difficulties (a.k.a. “chemo brain”):
– Teach regarding avoidance of multi-tasking, use of daily planner
• Mucositis:
– Teach regarding bland/soft foods, oral care, topical anesthetics
• Nausea/vomiting:
– Prophylactic and scheduled or PRN antiemetics (Zofran)
• Anorexia:
– Small, frequent, high-calorie meals, consider appetite stimulant
SAMPLE NURSING INTERVENTIONS
• Diarrhea:
– Administer anti-diarrheals, encourage fluid intake
• Constipation:
– Administer stool softeners, encourage activity
• Fatigue:
– Encourage exercise as tolerated, activity pacing and rest
• Psychosocial:
– Active listening, trust building, support usual lifestyle patterns, networking, family
care
• Myelosuppression and radiation burns:
– See case study
ONCOLOGIC
EMERGENCIES
• DIC
• SIADH
• Sepsis
• Tumor lysis
syndrome
• Third space
syndrome
• Cardiac
tamponade
• Spinal cord
compression
• Hypercalcemia
• Carotid artery • Superior vena
cava syndrome
rupture
METABOLIC ,
INFILTRATIVE,
OBSTRUCTIVE
STEP ONE: MOVE TO YOUR COLOR-CODED
AREA AND BEGIN DISCUSSION
• Light green group up front
– Find those with the same
oncologic emergency as you and
start researching details
• Everyone else
– Compare your sheets and start
deciding which oncologic
emergency you are from the
previous slide
– When you have your answer,
see me. If your answer is
correct, your “light green”
partners will join you!
STEP TWO: DECIDE APPROPRIATE
NURSING INTERVENTIONS
• Use the table provided to decide the best row of
interventions for your emergency.
• When you have your answer, see me to be awarded
the “buff” colored sheet with those interventions
• Decide whether your emergency is metabolic,
infiltrative, or obstructive
• Prepare a 60-second-or-less summary to share with
the class including type of emergency, cause/risk,
assessment, and intervention
STEP THREE: SURPRISE
Download